Secured Category III CPT Codes Pave the Way for Broader Access to Regenerative Skin ConstructSALT LAKE CITY, Oct. 29, 2025…
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early…
PETACH TIKVA, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company…
Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to…
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…
MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the…
The Harbinger Report Outlines The Firm's Independent Estimates For Significant Revenue Growth In The Coming Years Harbinger Research Initiates Coverage,…
COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby…
Investment vehicle provides diversified exposure to real-world assets and expected to reduce portfolio volatility Strategic allocation aligns with Silo’s objective…
Novel platform combining imaging, AI, and robotics aims to enhance IV placement success rates and patient experienceMIAMI, Oct. 29, 2025…